The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
p53 dynamics vary between tissues and are linked with radiation sensitivity
Abstract
Radiation sensitivity varies greatly between tissues. The transcription factor p53 mediates the response to radiation; however, the abundance of p53 protein does not correlate well with the extent of radiosensitivity across tissues. Given recent studies showing that the temporal dynamics of p53 influence the fate of cultured cells in response to irradiation, we set out to determine the dynamic behavior of p53 and its impact on radiation sensitivity in vivo. We find that radiosensitive tissues show prolonged p53 signaling after radiation, while more resistant tissues show transient p53 activation. Sustaining p53 using a small molecule (NMI801) that inhibits Mdm2, a negative regulator of p53, reduced viability in cell culture and suppressed tumor growth. Our work proposes a mechanism for the control of radiation sensitivity and suggests tools to alter the dynamics of p53 to enhance tumor clearance. Similar approaches can be used to enhance killing of cancer cells or reduce toxicity in normal tissues following genotoxic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Radiosensitive tissues such as the thymus, spleen, and lymphoid organs exhibit prolonged p53 signaling and transcription of p53 target genes after radiation. However, in epithelial cells such as those in the small and large intestines, more transitory p53 activation is associated with transient expression of its target genes.72”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820
Self-citationPhase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors
Wagner, A. J., Banerji, U., Mahipal, A., Somaiah, N., Hirsch, H., Fancourt, C., Johnson-Levonas, A. O., Lam, R., Meister, A. K., Russo, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.7117 · Cited by 120
Research works printed but not linked: 34
- Bernstein, A. & Lee, J. M. p53 mutations increase resistance to ionizing radiation. PNAS 90, 5742–5746 (1993). · DOI
- Patt, H. Factors in the radiosensitivity of mammalian cells. Ann. N. Y. Acad. Sci. 59, 649–664 (1955). · DOI
- Schjeide, O. A., Mead, J. F. & Myers, L. S. Jr. Notions on sensitivity of cells to radiation. Science 123, 1020–1022 (1956). · doi:10.1126/science.123.3206.1020
- Komarova, E. A. et al. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene 23, 3265–3271 (2004). · DOI · Paper page
- Midgley, C. A. et al. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci. 108, 1843–1848 (1995). · DOI · Paper page
- Gudkov, A. V. & Komarova, E. A. The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer 23, 117–129 (2003). · DOI · Paper page
- Bouvard, V. et al. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene 19, 649–660 (2000). · DOI · Paper page
- Komarova, E. A. et al. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16, 1391–1400 (1997). · DOI · Paper page
- Purvis, J. E. et al. p53 dynamics control cell fate. Science 336, 1440–1444 (2012). · DOI · Paper page
- Paek, A. L., Liu, J. C., Loewer, A., Forrester, W. C. & Lahav, G. Cell-to-cell variation in p53 dynamics leads to fractional killing. Cell 165, 631–642 (2016). · DOI · Paper page
- Chen, S. H., Forrester, W. & Lahav, G. Schedule-dependent interaction between anticancer treatments. Science 351, 1204–1208 (2016). · DOI
- Lev Bar-Or, R. et al. Generation of oscillation by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc. Natl Acad. Sci. USA 97, 11250–11255 (2000). · DOI · Paper page
- Burgess, A. et al. Clinical overview of MDM2/X-targeted therapies. Front. Oncol. 6, 7 (2016). · DOI · Paper page
- Sanz, G., Singh, M., Peuget, S. & Selivanova, G. Inhibition of p53 inhibitors: progress, challenges and perspectives. J. Mol. Cell Biol. 11, 586–599 (2019). · DOI
- Stewart-Ornstein, J. & Lahav, G. p53 dynamics in response to DNA damage vary across cell lines and are shaped by efficiency of DNA repair and activity of the kinase ATM. Sci. Signal. 10, eaah6671 (2017). · DOI
- Hamstra, D. A. et al. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res. 66, 7482–7489 (2006). · DOI
- Fei, P., Bernhard, E. J. & El-Deiry, W. S. Tissue-specific induction of p53 targets in vivo. Cancer Res. 62, 7316–7327 (2002).
- Gurley, K. E., Ashley, A. K., Moser, R. D. & Kemp, C. J. Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation. Cell Death Differ. 54, 61 (2017).
- Hua, G. et al. Crypt base columnar stem cells in small intestines of mice are radioresistant. Gastroenterology 143, 1266–1276 (2012). · DOI · Paper page
- Qiu, W. et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell. Stem Cell. 2, 576–583 (2008). · DOI · Paper page
- Yu, H. et al. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation. Blood 115, 3472–3480 (2010). · DOI
- MacCallum, D. E. et al. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 13, 2575–2587 (1996).
- Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674–1677 (1998). · DOI · Paper page
- Furet, P. et al. The Central valine concept provides an entry in a new class of non peptide inhibitors of the p53-mdm2 interaction. Bioorg. Med. Chem. Lett. 22, 3498–3502 (2012). · DOI
- Spiegelberg, D. et al. The MDM2/MDMX-p53 antagonist PM2 radiosensitizes wild-type p53 tumors. Cancer Res. 78, 5084–5093 (2018). · DOI
- Hafner, A., Kublo, L., Tsabar, M., Lahav, G. & Stewart-Ornstein, J. Identification of universal and cell- type specific p53 DNA binding. BMC Mol. Cell Biol. 21, 5 (2020). · DOI
- Moyer, S. M. et al. p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo. Proc. Natl Acad. Sci. USA. 117, 23663–23673 (2020). · DOI
- Wang, X. et al. Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiation. Sci. Rep. 5, 8566 (2015). · DOI
- Tisato, V., Voltan, R., Gonelli, A., Secchiero, P. & Zauli, G. MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer. J. Hematol. Oncol. 10, 133 (2017). · DOI · Paper page
- Welliver, M. X. et al. MDM2 inhibitor AMG-232 and radiation therapy in treating patients with soft tissue sarcoma with wild-type TP53: a phase IB study (NRG-DT001). J. Clin. Oncol. 37 (15_Suppl.) https://doi.org/10.1200/JCO.2019.37.15_suppl.TPS11076 (2019). · DOI
- Kabsch, W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 66, 125–132 (2010). · DOI · Paper page
- Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. Biol. Crystallogr. 50, 760–763 (1994). · DOI · Paper page
- Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126–2132 (2004). · DOI · Paper page
- Miller, M. A. et al. Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts. Sci. Transl. Med. 9, eaal0225 (2017). · DOI · Paper page
Cited by
Molecular mechanisms of tumor resistance to radiotherapy
Wu, Y., Song, Y., Wang, R., & Wang, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01801-2 · Cited by 527
Understanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
MDM2/X inhibitors as radiosensitizers for glioblastoma targeted therapy
Miles, X., Vandevoorde, C., Hunter, A., & Bolcaen, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.703442 · Cited by 40
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Mills, M., Emori, C., Kumar, P., Boucher, Z., George, J., & Bolcun-Filas, E. (2025) · Developmental Biology · doi:10.1016/j.ydbio.2024.09.007 · Cited by 12
Metadata
- Authors
- Stewart-Ornstein, J., Iwamoto, Y., Miller, M. A., Prytyskach, M. A., Ferretti, S., Holzer, P., Kallen, J., Furet, P., Jambhekar, A., Forrester, W. C., Weissleder, R., & Lahav, G.
- Venue
- Nature Communications
- Published
- 2021-02-09
- Volume
- 12
- Issue
- 1
- ISSN
- 2041-1723
- Cited by
- 88
- References
- 5
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p53 dynamics vary between tissues and are linked with radiation sensitivity. https://app.cochat.ai/papers/10.1038/s41467-021-21145-z
- The paper
- Stewart-Ornstein, J., Iwamoto, Y., Miller, M. A., Prytyskach, M. A., Ferretti, S., Holzer, P., Kallen, J., Furet, P., Jambhekar, A., Forrester, W. C., Weissleder, R., & Lahav, G. (2021). p53 dynamics vary between tissues and are linked with radiation sensitivity. Nature Communications. https://doi.org/10.1038/s41467-021-21145-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.